Protriptyline: Difference between revisions
No edit summary |
|||
Line 40: | Line 40: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
==VIVACTIL (protriptyline hydrochloride) tablet | ==VIVACTIL (protriptyline hydrochloride) tablet== | ||
''' [[VIVACTIL (protriptyline hydrochloride) tablet indications and usage|Indications and Usage]]''' | ''' [[VIVACTIL (protriptyline hydrochloride) tablet indications and usage|Indications and Usage]]''' |
Revision as of 19:23, 12 February 2014
Protriptyline |
---|
VIVACTIL (protriptyline hydrochloride) tablet® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Protriptyline |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Protriptyline, click here.
Synonyms / Brand Names: Vivactil®®
Overview
File:Protriptyline.png | |
Clinical data | |
---|---|
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 54-92 hours |
Excretion | Renal, in urine |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C19H21N |
Molar mass | 263.377 g/mol |
Protriptyline is a tricyclic antidepressant (TCA), specifically a secondary amine, indicated for depression and ADHD. Unique among the tricyclics, protriptyline tends to be energizing instead of sedating, and it is sometimes used in narcolepsy to achieve a wakefulness-promoting effect.[citation needed] (The other TCAs tend to be sedating and therefore are often taken in the evening.)
Tricyclics including protriptyline are also used to reduce the incidence of recurring headaches such as migraine, and for other types of chronic pain.
Category
FDA Package Insert
VIVACTIL (protriptyline hydrochloride) tablet
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
[1] Normal 0 false false false EN-US X-NONE X-NONE
References
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from November 2007
- Articles with invalid date parameter in template
- Drugs
- Tricyclic antidepressants